Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
ASAIO J ; 68(10): 1228-1230, 2022 10 01.
Artículo en Inglés | MEDLINE | ID: mdl-35667305

RESUMEN

Infection with the novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), may cause viral pneumonia and acute respiratory distress syndrome (ARDS). Treatment of ARDS often requires mechanical ventilation and may take weeks for resolution. In areas with a large outbreaks, there may be shortages of ventilators available. While rudimentary methods for ventilator splitting have been described, given the range of independent ventilatory settings required for each patient, this solution is suboptimal. Here, we describe a device that can split a ventilator among up to four patients while allowing for individualized settings. The device has been validated in vitro and in vivo .


Asunto(s)
COVID-19 , Neumonía Viral , Síndrome de Dificultad Respiratoria , Humanos , Neumonía Viral/terapia , Respiración Artificial , Síndrome de Dificultad Respiratoria/terapia , SARS-CoV-2 , Ventiladores Mecánicos
2.
Cell Rep ; 21(6): 1681-1691, 2017 Nov 07.
Artículo en Inglés | MEDLINE | ID: mdl-29117570

RESUMEN

Oxytocin is a hormone with various actions. Oxytocin-containing parvocellular neurons project to the brainstem and spinal cord. Oxytocin release from these neurons suppresses nociception of inflammatory pain, the molecular mechanism of which remains unclear. Here, we report that the noxious stimulus receptor TRPV1 is an ionotropic oxytocin receptor. Oxytocin elicits TRPV1 activity in native and heterologous expression systems, regardless of the presence of the classical oxytocin receptor. In TRPV1 knockout mice, DRG neurons exhibit reduced oxytocin sensitivity relative to controls, and oxytocin injections significantly attenuate capsaicin-induced nociception in in vivo experiments. Furthermore, oxytocin potentiates TRPV1 in planar lipid bilayers, supporting a direct agonistic action. Molecular modeling and simulation experiments provide insight into oxytocin-TRPV1 interactions, which resemble DkTx. Together, our findings suggest the existence of endogenous regulatory pathways that modulate nociception via direct action of oxytocin on TRPV1, implying its analgesic effect via channel desensitization.


Asunto(s)
Nocicepción/efectos de los fármacos , Oxitocina/farmacología , Canales Catiónicos TRPV/genética , Animales , Calcio/metabolismo , Capsaicina/análogos & derivados , Capsaicina/farmacología , Células Cultivadas , Potenciales Evocados/efectos de los fármacos , Femenino , Ganglios Espinales/citología , Células HEK293 , Humanos , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Neuronas/citología , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Estructura Cuaternaria de Proteína , Receptores de Oxitocina/antagonistas & inhibidores , Receptores de Oxitocina/genética , Receptores de Oxitocina/metabolismo , Canales Catiónicos TRPV/agonistas , Canales Catiónicos TRPV/antagonistas & inhibidores , Canales Catiónicos TRPV/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...